Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

The Shuman Law Firm Investigates Galena Biopharma, Inc.

Business Wire March 19, 2014

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Galena Biopharma, Inc.

PR Newswire March 19, 2014

Milberg LLP Announces Pendency of a Class Action Lawsuit Against Galena Biopharma, Inc.

PR Newswire March 19, 2014

Hagens Berman Investigating Galena Biopharma and CytRx Corporation for Securities Fraud; Notifies Investors of Deadlines

Business Wire March 19, 2014

Galena Biopharma Inc. Share Value Tumbles on News of SEC Investigation

Accesswire March 19, 2014

GALENA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Galena Biopharma, Inc. -- GALE

GlobeNewswire March 18, 2014

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE

PR Newswire March 18, 2014

Galena Biopharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire March 18, 2014

ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Class Action Deadline -- GALE

Marketwired March 18, 2014

Block & Leviton LLP Investigates Galena Biopharma, Inc. after acknowledgment of SEC Investigation, for Possible Violations of the Federal Securities Laws

PR Newswire March 18, 2014

Galena Biopharma Reports Fourth Quarter and Year End 2013 Results

GlobeNewswire March 17, 2014

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Galena Biopharma, Inc. to Contact the Firm

Marketwired March 14, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Galena Biopharma, Inc. and Certain Officers -- GALE

GlobeNewswire March 12, 2014

Attention Galena Biopharma, Inc. Investors: Galena Misled Investors According to a Recently Filed Class Action

PR Newswire March 12, 2014

Wolf Haldenstein Announces Investigation of Galena Biopharma, Inc.

Business Wire March 11, 2014

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE

Marketwired March 11, 2014

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Files Class Action Lawsuit Against Galena Biopharma, Inc.

Business Wire March 11, 2014

Lawsuit on Behalf of Investors in Galena Biopharma Inc (GALE) Announced by Shareholders Foundation

GlobeNewswire March 10, 2014

Shareholder Rights Law Firm Johnson & Weaver, LLP Has Filed a Class Action Lawsuit Against Galena Biopharma, Inc. and Certain Officers

Business Wire March 8, 2014

EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Against Galena Biopharma, Inc. -- GALE

GlobeNewswire March 7, 2014